Ex-vivo isolated cd25+cd4+ t cells with immunosuppressive activity and uses thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
N/A
app pub date -
May 7, 2004
filing date -
May 30, 2001
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
Ex-vivo isolated human CD25.sup.+CD4.sup.+ T regulatory cells, CD25.sup.+CD4.sup.+ Tr cell clones derived therefrom, a method of isolating clones and the use of ex-vivo isolated human CD25.sup.+CD4.sup.+ Tr cells or cell-clones as immunomodulators, immunosuppressive agents or for the identification of molecules that modulate the immune response.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully